Limitation of life sustaining therapy in disorders of consciousness: ethics and practice
Brain · 05.07.2024 · 147 (7) · 2274-2288
DOI: 10.1093/brain/awae060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, online erschienen am 22.02.2024. Verfasst von India A Lissak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Consciousness Disorders, Life Support Care, Withholding Treatment. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Common Fund, NIMH NIH HHS, BRAIN Initiative.
Themen: Ethik in der Pflege
Abstract (Originalsprache)
Clinical conversations surrounding the continuation or limitation of life-sustaining therapies (LLST) are both challenging and tragically necessary for patients with disorders of consciousness (DoC) following severe brain injury. Divergent cultural, philosophical and religious perspectives contribute to vast heterogeneity in clinical approaches to LLST—as reflected in regional differences and inter-clinician variability. Here we provide an ethical analysis of factors that inform LLST decisions among patients with DoC. We begin by introducing the clinical and ethical challenge and clarifying the distinction between withdrawing and withholding life-sustaining therapy. We then describe relevant factors that influence LLST decision-making including diagnostic and prognostic uncertainty, perception of pain, defining a ‘good’ outcome, and the role of clinicians. In concluding sections, we explore global variation in LLST practices as they pertain to patients with DoC and examine the impact of cultural and religious perspectives on approaches to LLST. Understanding and respecting the cultural and religious perspectives of patients and surrogates is essential to protecting patient autonomy and advancing goal-concordant care during critical moments of medical decision-making involving patients with DoC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
ORCID-Profile: India A Lissak, Michael J Young
Förderung
- Common Fund
- NIMH NIH HHS
- BRAIN Initiative
- NIH HHS
- American Academy of Neurology
- National Institutes of Health
Zitieren
APA
Lissak, I. A., & Young, M. J. (2024). Limitation of life sustaining therapy in disorders of consciousness: ethics and practice. Brain, 147(7), 2274-2288. https://doi.org/10.1093/brain/awae060
Vancouver
Lissak IA, Young MJ. Limitation of life sustaining therapy in disorders of consciousness: ethics and practice. Brain. 2024;147(7):2274-2288. doi:10.1093/brain/awae060
BibTeX
@article{Lissak2024,
author = {Lissak, India A and Young, Michael J},
title = {Limitation of life sustaining therapy in disorders of consciousness: ethics and practice},
journal = {Brain},
year = {2024},
volume = {147},
number = {7},
pages = {2274--2288},
doi = {10.1093/brain/awae060}
}
EUVIMED